Reach Us +44-1647-403003
HIF-1 is the Commander of Gateways to Cancer | OMICS International | Abstract
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

HIF-1 is the Commander of Gateways to Cancer

Nagy MA*

Department of Chemistry, College of Science, Beni-Suef University, Beni-Suef, Egypt

*Corresponding Author:
Dr. Nagy MA
Department of Chemistry
College of Science
Beni-Suef University
Beni-Suef, Egypt
Tel: +20862375623, +20175011129
E-mail: [email protected]

Received date: October 02, 2010; Accepted date: November 13, 2010;; Published date: December 15, 2010

Citation: Nagy MA (2011) HIF-1 is the Commander of Gateways to Cancer. J Cancer Sci Ther 3: 035-040. doi: 10.4172/1948-5956.1000054

Copyright: © 2011 Nagy MA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.


The hypoxia-inducible factor-1 (HIF-1) is primarily involved in the sensing and adapting of cells to changes in the O2 level, which is essential for their viability. An increased activity is recognized in the majority of clinical relevant hypoxic/ischemic episodes and human cancers .HIF-1 is considered a central regulator of the adaptation response of cancer cells to hypoxia that makes it a therapeutic target in solid tumors. In this article, the biochemical pathways that are regulated by HIF-1 and the factors that regulate HIF-1 expression are briefly discussed .as targeting HIF-1, may selectively kill tumor cells that adapt to low O2 concentrations.


Share This Page